ARCHIVES

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

This article is from The Cancer Letter archive.

Vol. 10 No. 30 | July 27, 1984

Download PDF Visit The Full Archive

Related Articles

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

House Still Sees Problems In NIH Financial Management

July 5, 1991

New Publications

January 20, 1989

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979